LncRNA FAM83A-AS1 promotes epithelial–mesenchymal transition of pancreatic cancer cells via Hippo pathway

References

• Siegel RL, Miller KD, Fuchs HE, et al. Cancer statistics, 2022. CA Cancer J Clin. 2022;72(1):7–33.
   PubMed Web of Science ®Google Scholar
• Wood LD, Canto MI, Jaffee EM, et al. Pancreatic cancer: pathogenesis, screening, diagnosis, and treatment. Gastroenterology. 2022;163(2):386–402.e1.
   PubMed Web of Science ®Google Scholar
• Nojima T, Proudfoot NJ. Mechanisms of lncRNA biogenesis as revealed by nascent transcriptomics. Nat Rev Mol Cell Biol. 2022;23(6):389–406.
   PubMed Web of Science ®Google Scholar
• Chen YT, Kan CH, Liu H, et al. Modular scaffolding by lncRNA HOXA10-AS promotes oral cancer progression. Cell Death Dis. 2022;13(7):629.
   PubMed Web of Science ®Google Scholar
• Zhou C, Yi C, Yi Y, et al. LncRNA PVT1 promotes gemcitabine resistance of pancreatic cancer via activating Wnt/β-catenin and autophagy pathway through modulating the miR-619-5p/Pygo2 and miR-619-5p/ATG14 axes. Mol Cancer. 2020;19(1):118.
   PubMed Web of Science ®Google Scholar
• Shi R, Jiao Z, Yu A, et al. Long noncoding antisense RNA FAM83A-AS1 promotes lung cancer cell progression by increasing FAM83A. J Cell Biochem. 2019;120(6):10505–10512.
   PubMed Web of Science ®Google Scholar
• Chen Z, Hu Z, Sui Q, et al. LncRNA FAM83A-AS1 facilitates tumor proliferation and the migration via the HIF-1α/glycolysis axis in lung adenocarcinoma. Int J Biol Sci. 2022;18(2):522–535.
   PubMed Web of Science ®Google Scholar
• Zhao H, Wang Y, Wu X, et al. FAM83A antisense RNA 1 (Fam83A-AS1) silencing impairs cell proliferation and induces autophagy via MET-AMPKα signaling in lung adenocarcinoma. Bioengineered. 2022;13(5):13312–13327.
   PubMed Web of Science ®Google Scholar
• Jia J, Li H, Chu J, et al. LncRNA FAM83A-AS1 promotes ESCC progression by regulating miR-214/CDC25B axis. J Cancer. 2021;12(4):1200–1211.
   PubMed Web of Science ®Google Scholar
• He J, Yu J. Long noncoding RNA FAM83A-AS1 facilitates hepatocellular carcinoma progression by binding with NOP58 to enhance the mRNA stability of FAM83A. Biosci Rep. 2019;39(11):BSR20192550.
   PubMedGoogle Scholar
• Zhou C, Liang Y, Zhou L, et al. TSPAN1 promotes autophagy flux and mediates cooperation between WNT-CTNNB1 signaling and autophagy via the MIR454-FAM83A-TSPAN1 axis in pancreatic cancer. Autophagy. 2021;17(10):3175–3195.
   PubMed Web of Science ®Google Scholar
• Hänzelmann S, Castelo R, Guinney J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinf. 2013;14:7.
   PubMed Web of Science ®Google Scholar
• Liu L, Han S, Xiao X, et al. Glucocorticoid-induced microRNA-378 signaling mediates the progression of pancreatic cancer by enhancing autophagy. Cell Death Dis. 2022;13(12):1052.
   PubMed Web of Science ®Google Scholar
• Li F, Negi V, Yang P, et al. TEAD1 regulates cell proliferation through a pocket-independent transcription repression mechanism. Nucleic Acids Res. 2022;gkac1063(22):12723–12738.
   Google Scholar
• Papadakos SP, Dedes N, Gkolemi N, et al. The EPH/ephrin system in Pancreatic Ductal Adenocarcinoma (PDAC): from pathogenesis to treatment. Int J Mol Sci. 2023;24(3):3015.
   PubMed Web of Science ®Google Scholar
• Papadakos SP, Dedes N, Pergaris A, et al. Exosomes in the treatment of pancreatic cancer: a moonshot to PDAC treatment? Int J Mol Sci. 2022;23(7):3620.
   PubMed Web of Science ®Google Scholar
• Bridges MC, Daulagala AC, Kourtidis A. Lnccation: lncRNA localization and function. J Cell Bio. 2021;220(2):e202009045.
   PubMed Web of Science ®Google Scholar
• Herman AB, Tsitsipatis D, Gorospe M. Integrated lncRNA function upon genomic and epigenomic regulation. Mol Cell. 2022;82(12):2252–2266.
   PubMed Web of Science ®Google Scholar
• Cai Y, Lyu T, Li H, et al. LncRNA CEBPA-DT promotes liver cancer metastasis through DDR2/β-catenin activation via interacting with hnRNPC. J Exp Clin Cancer Res. 2022;41(1):335.
   PubMed Web of Science ®Google Scholar
• Li D, Shen L, Zhang X, et al. LncRNA ELF3-AS1 inhibits gastric cancer by forming a negative feedback loop with SNAI2 and regulates ELF3 mRNA stability via interacting with ILF2/ILF3 complex. J Exp Clin Cancer Res. 2022;41(1):332.
   PubMed Web of Science ®Google Scholar
• Kwon MR, Lee JH, Park J, et al. NCK-associated protein 1 regulates metastasis and is a novel prognostic marker for colorectal cancer. Cell Death Discov. 2023;9(1):7.
   PubMed Web of Science ®Google Scholar
• Hashemi M, Hajimazdarany S, Mohan CD, et al. Long non-coding RNA/epithelial-mesenchymal transition axis in human cancers: tumorigenesis, chemoresistance, and radioresistance. Pharmacol Res. 2022;186:106535.
   PubMed Web of Science ®Google Scholar
• Khan MI, Ahmad A. LncRNA SNHG6 sponges miR-101 and induces tamoxifen resistance in breast cancer cells through induction of EMT. Front Oncol. 2022;12:1015428.
   PubMed Web of Science ®Google Scholar
• Zhang H, Zhu C, He Z, et al. LncRNA PSMB8-AS1 contributes to pancreatic cancer progression via modulating miR-382-3p/STAT1/PD-L1 axis. J Exp Clin Cancer Res. 2020;39(1):179.
   PubMed Web of Science ®Google Scholar
• Sharma U, Tuli HS, Uttam V, et al. Role of Hedgehog and Hippo signaling pathways in cancer: a special focus on non-coding RNAs. Pharmacol Res. 2022;186:106523.
   PubMed Web of Science ®Google Scholar
• Fu M, Hu Y, Lan T, et al. The Hippo signalling pathway and its implications in human health and diseases. Signal Transduct Target Ther. 2022;7(1):376.
   PubMed Web of Science ®Google Scholar
• Liu S, Li H, Zhu Y, et al. LncRNA MNX1-AS1 sustains inactivation of Hippo pathway through a positive feedback loop with USP16/IGF2BP3 axis in gallbladder cancer. Cancer Lett. 2022;547:215862.
   PubMed Web of Science ®Google Scholar
• Xu M, Cui R, Ye L, et al. LINC00941 promotes glycolysis in pancreatic cancer by modulating the Hippo pathway. Mol Ther Nucleic Acids. 2021;26:280–294.
   PubMedGoogle Scholar
• Zhang M, Zhao Y, Zhang Y, et al. LncRNA UCA1 promotes migration and invasion in pancreatic cancer cells via the Hippo pathway. Biochim Biophys Acta Mol Basis Dis. 2018;1864(5):1770–1782.
   PubMed Web of Science ®Google Scholar